Picture of Incyte logo

INCY Incyte Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Annual cashflow statement for Incyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line447-296949341598
Depreciation
Deferred Taxes
Non-Cash Items152191223306224
Unusual Items
Other Non-Cash Items
Changes in Working Capital57.3-71.7-14.6199-249
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities711-125749970496
Capital Expenditures-78.1-187-181-77.8-32.5
Purchase of Fixed Assets
Other Investing Cash Flow Items-9.39-81.6-26.7-0.709-175
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Cash from Investing Activities-87.5-269-208-78.5-208
Financing Cash Flow Items-16.8-37.8-50-59-52.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities45.771.76.18-0.794-20
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash669-319544894262